Target intelligence / Profile preview

Mas-related G protein-coupled receptor C11 (MrgprC11)

Target
MrgprC11
Molecular classification
G protein-coupled receptor, Class A GPCR, Sensory neuron-specific receptor
01

Overview

Mas-related G protein-coupled receptor C11 (MrgprC11) is a member of the Mas-related GPCR subfamily, a group of class A (rhodopsin-like) G protein-coupled receptors primarily found in small-diameter, sensory neurons of the dorsal root ganglia in rodents. MrgprC11 is involved in the detection and modulation of noxious stimuli, including pain and itch, and has become a focus of research as a potential novel target for the treatment of persistent pain syndromes and chronic itch. In experimental models, activation of MrgprC11 with the peptide agonist BAM8-22 yields analgesic and antipruritic effects, suggesting therapeutic promise. MrgprC11 couples primarily to Gi and Gq signaling pathways, leading to the inhibition of neuronal excitability. Its expression pattern is highly restricted to sensory neurons, which may offer the opportunity for selective therapeutic modulation with minimal systemic side effects. Current evidence for MrgprC11 comes largely from rodent studies; no pathophysiologically equivalent receptor ortholog is established in humans, but related MRGPRX receptors exist.

Other names
MrgprC11Mrgprc11 (mouse)MAS-related GPRCBAM22 receptor
02

Mechanism of action

Agonists (such as BAM8-22) activate MrgprC11 in nociceptive neurons, leading to inhibition of high voltage–activated calcium channels and reduced neurotransmitter release, thereby modulating pain transmission. Engages downstream Gi and Gq protein signaling pathways

03

Biological functions

Signal transductionNociception (pain sensation)Itch (pruritus) signalingModulation of neuronal excitability
04

Disease associations

Pain (neuropathic and inflammatory)Itch (chronic pruritus)Potential roles in gastrointestinal disorders (visceral hypersensitivity)
05

Safety considerations

Highly specific neuronal expression suggests limited off-target toxicity, but the lack of clinical experience means safety concerns remain largely theoreticalThe potential to influence pain perception could theoretically lead to altered sensory or nociceptive responses
06

Interacting drugs

BAM8-22 (bovine adrenal medulla peptide 8-22; peptide agonist in rodents)

1 more in the full profile.

07

Biomarkers

Expression of MrgprC11 in small-diameter primary sensory neurons (may serve as a stratifying biomarker in research)No established clinical biomarkers for patient selection or efficacy

Beyond the preview

Go deeper on Mas-related G protein-coupled receptor C11 (MrgprC11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mas-related G protein-coupled receptor C11 (MrgprC11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call